Weill Medical College of Cornell University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

346

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

13 drugs in development

Approved1

Phase 31

Phase 210

Phase 15

Preclinical2

By Therapeutic Area

top 6

Oncology

737%

Musculoskeletal

211%

Neurology

15%

Psychiatry

15%

Infectious Disease

15%

Metabolic & Endocrine

15%

R&D Momentum

79/100

Pipeline Velocity

46/100

Trial Completion Rate

57/100

Pipeline Concentration

23/100

Pipeline Freshness

49/100

Strategic Signals

↗Active in Musculoskeletal but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Jul 9, 2026

Recruiting

Technology Tools for Cognitive Support for Health Management Activities for Aging Adults With and Without Mild Cognitive Impairment (Research Project 3)

Jul 9, 2026

Completed

Optimizing Delivery of Diabetes Management During Breast Cancer Care

Jul 1, 2026

Active, not recruiting

Randomized Controlled Trial of Accessible Online Genetic Services for Cascade Testing for BRCA Mutation Carriers Versus Usual Care in a Clinic Setting

Earlier

Jun 27, 2026TrialOptimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries

Jun 27, 2026TrialUnderstanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study

Jun 27, 2026TrialA Technology-based Psychosocial Intervention to Support Social Engagement and Well-being in Older Adults With HIV

Jun 27, 2026TrialA Pilot Trial of Bright Light Therapy in Patients Receiving First Line Immune Checkpoint Blockade

Jun 25, 2026TrialPhase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)

1 more events

Jun 25, 2026TrialEffect of an Educational Nail Biopsy Video on Pre-operative Anxiety, Health Literacy, and Patient Satisfaction: a Single Center Randomized Controlled Trial

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Gastroenterology(1 drug)

—

Gastroenterology(1 drug)

Infectious Disease(1 drug)

—

Infectious Disease(1 drug)

Metabolic & Endocrine(1 drug)

—

Metabolic & Endocrine(1 drug)

Musculoskeletal(2 drugs)

—

Musculoskeletal(2 drugs)

Neurology(1 drug)

—

Neurology(1 drug)

Oncology(7 drugs)

—

Oncology(7 drugs)

Psychiatry(1 drug)

—

Psychiatry(1 drug)

Unknown / Other(5 drugs)

—

Unknown / Other(5 drugs)

Regulatory

Regulatory Timeline

19941 event

FDAAug 19

Fludeoxyglucose F18 — FLUDEOXYGLUCOSE F18

Application NDA020306 (NDA)

20041 event

FDAAug 5

Fludeoxyglucose F18 — FLUDEOXYGLUCOSE F18

Application NDA021768 (NDA)

20051 event

FDAAug 19

Fludeoxyglucose F18 — FLUDEOXYGLUCOSE F18

Application NDA021870 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)